ARCHIVES

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

This article is from The Cancer Letter archive.

Vol. 11 No. 05 | February 1, 1985

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Reissuing Surgical Oncology RFA For Planning, Okays New Recompleting Projects

June 17, 1983

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI

January 7, 1977

Reinventing NCI: clinical Trials report Calls for Study Section, increased Funding For Cooperative Groups

October 3, 1997

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992